Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
The effect of o-3fa nutritional supplement on primary dysmenorrhea: a randomized controlled trial
Author(s):
1. Ali Hamza Arshad: DHQ Hospital, Sheikhupura, Pakistan
2. Ayesha Abdul Wahid: Superior university Lahore, Pakistan
Abstract:
Background: Primary dysmenorrhea is a prevalent gynaecological condiotin that aefcts many females and is also referred to as menstruation cramps. Because of its anti -inflammatory quality, O-3FAs (OFA) supplementation has been recommended as a possible alternative to pharmaceuctial therapy for primary dysmenorrhea. Objective: The objecvtie was to determine the OFA supplementation eefct on menstrual pain severity and menstrual cycle duration in women with primary dysmenorrhea. Methods: A randomised controlled trial was conducted at vfie major universietis/Colleges lasted for a total of six months. A randomizati on procedure was used to determine whether treatment, OFA supplementaotin or a placebo, each of 48 primary dysmenorrheic women aged 24 to 40 would receive. A visual analogue scale (VAS) and a calendar approach were used, respecvtiely, to determine the leve l of menstrual discomfort and the duration of the menstrual cycle at both the beginning of the study and aeftr the intervenotin. Results: The mean menstrual pain severity in the intervenotin group decreased significantly from 7.2 ± 1.1 at baseline to 4.5 ± 1.3 post-intervention, whereas the mean menstrual pain severity in the control group remained relatively unchanged from baseline (7.4 ± 1.2) to post-intervenotin (6.9 ± 1.1). The mean menstrual cycle duration in the intervention group decreased from 28.4 ± 2.1 days at baseline to 4.8 ± 0.7 days post-intervenotin, but the diefrence observed in two groups was not significant. The baseline characteristics of the intervention and control groups were similar, indicating eefctive randomization. Conclusion: OFA supplement found to be an effective non-pharmaceutical therapy for primary  dysmenorrhea, since it significantly lowers the degree of menstrual discomfort compared to placebo.
Page(s): 13-19
DOI: DOI not available
Published: Journal: Journal of Health and Rehabilitation Research, Volume: 2, Issue: 2, Year: 2022
Keywords:
supplementation , Primary Dysmenorrhea , O3FA , menstrual pain severity , menstrual cycle duration
References:
References are not available for this document.
Citations
Citations are not available for this document.
0

Citations

0

Downloads

4

Views